Curated News:

National Institute of Allergy and Infectious Diseases (NIAID)

Add to Favorites Subscribe Share
fbshare-National Institute of Allergy and Infectious Diseases (NIAID)

Showing results

16 of 6

Article ID: 719813

Duke Vaccine Institute Plays Integral Role in National Effort to Improve Flu Shots

Duke Clinical Research Institute

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases (NIAID), with an initial award of approximately $29.6 million in first-year funding.

Released:
30-Sep-2019 11:05 AM EDT
UM_School_Medicine.png

Article ID: 719390

UM School of Medicine’s Center for Vaccine Development and Global Health Receives NIH Contract for Influenza Research

University of Maryland School of Medicine

The National Institute of Allergy and Infectious Diseases research contract is one of the largest ever awarded to UMSOM and includes an initial award of approximately $2.5 million to conduct clinical testing of influenza vaccines. Total funding over seven years could be as much as $201 million if all options are exercised in the NIAID contract.

Released:
20-Sep-2019 2:05 PM EDT
Newswise: Starting HIV Treatment in ERs May Be Key to Ending HIV Spread Worldwide

Article ID: 718995

Starting HIV Treatment in ERs May Be Key to Ending HIV Spread Worldwide

Johns Hopkins Medicine

In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease. A report on the findings was published in August in EClinicalMedicine.

Released:
16-Sep-2019 10:05 AM EDT

Showing results

16 of 6

Chat now!